Targeted spleen modulation: a novel strategy for next-generation disease immunotherapy
Theranostics · 18.03.2025 · 15 (10) · 4416-4445
DOI: 10.7150/thno.111116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 18.03.2025. Verfasst von Wei Dong und 9 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center of Biodiagnostics and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'…. Hauptthemen laut MEDLINE: Spleen, Immunotherapy. Die Arbeit wurde bisher 48-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The spleen, the largest lymphatic organ, comprises a diverse array of immunocytes in approximately one quarter of the body, including T cells, B cells, natural killer cells, and myeloid cells (such as dendritic cells, neutrophils, myeloid-derived suppressor cells, and macrophages). These immune cells undergo dynamic transitions and mobilization, enabling the spleen to execute a wide range of immunological functions. The spleen's structural organization and multicellular composition, along with its reservoir of lymphocytes, facilitate the capture and clearance of blood-borne antigens while also orchestrating both innate and adaptive immune responses. Additionally, the spleen plays critical roles in hematopoiesis and the removal of aged or damaged red blood cells. Despite being innervated by sympathetic (catecholaminergic) nerve fibers, the spleen lacks parasympathetic (vagal or cholinergic) innervation. The neuroimmune axis, particularly the interplay between sympathetic and parasympathetic nervous system immune circuits, significantly influences disease onset and progression. Extensive research employing physical, genetic, and pharmacological approaches has sought to directly modulate splenic immunocytes and activate neuroimmune interactions to restore immune homeostasis and counteract disease. Two primary mechanisms underlie these immunomodulatory interventions: (1) the cholinergic anti-inflammatory pathway, wherein norepinephrine released by splenic catecholaminergic fibers binds to β2-adrenergic receptors on CD4⁺ T cells, triggering acetylcholine secretion, which in turn suppresses inflammatory cytokine production in macrophages via α7 nicotinic acetylcholine receptor signaling, and (2) direct immunomodulation of splenic immunocytes, which regulates key genes and signaling pathways, alters cytokine secretion, and modulates ion flux to influence cellular functions. Among various therapeutic strategies, physical methods, particularly electrical stimulation and splenic ultrasound stimulation, have demonstrated the greatest promise for clinical applications in splenic immunomodulation and disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National and Local Joint Engineering Research Center of Biodiagnostics and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
- Department of Geriatric General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
- Center for Tumor and Immunology, The Precision Medical Institute, Xi'an Jiaotong University, Xi'an, China.
- Shaanxi Provincial Clinical Medical Research Center for Liver and Spleen Diseases, CHESS-Shaanxi consortium, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
- Key Laboratory of Biomedical Information Engineering of Ministry of Education, Department of Biomedical Engineering, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China.
Zitieren
APA
Dong, W., Li, Y., Fei, Q., Li, S., He, X., Chai, Y., Zhou, J., Zong, Y., Geng, J., & Li, Z. (2025). Targeted spleen modulation: a novel strategy for next-generation disease immunotherapy. Theranostics, 15(10), 4416-4445. https://doi.org/10.7150/thno.111116
Vancouver
Dong W, Li Y, Fei Q, Li S, He X, Chai Y, et al. Targeted spleen modulation: a novel strategy for next-generation disease immunotherapy. Theranostics. 2025;15(10):4416-4445. doi:10.7150/thno.111116
BibTeX
@article{Dong2025,
author = {Dong, Wei and Li, Yucheng and Fei, Qiaoman and Li, Senyang and He, Xinrui and Chai, Yichao and Zhou, Junyi and Zong, Yujin and Geng, Jing and Li, Zongfang},
title = {Targeted spleen modulation: a novel strategy for next-generation disease immunotherapy},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {10},
pages = {4416--4445},
doi = {10.7150/thno.111116}
}
EUVIMED